Related Experiment Video
Updated: Aug 11, 2025
13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
19.6K
Lymphocyte Membrane- and 12p1-Dual-Functionalized Nanoparticles for Free HIV-1 Trapping and Precise siRNA Delivery
Jinbang Zhang1,2, Jingwan Han3, Hui Li1,2
1State key Laboratory of Toxicology and Medical Countermeasure, Department of Pharmaceutics, Beijing Institute of Pharmacology and Toxicology, Beijing, 100039, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|February 9, 2023
Summary
A novel nanoparticle system effectively neutralizes HIV-1 and delivers small interfering RNA (siRNA) to infected cells. This breakthrough offers a promising strategy for precise human immunodeficiency virus (HIV) therapy by overcoming delivery challenges.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Virology
Background:
- Small interfering RNA (siRNA) shows therapeutic potential for HIV but faces challenges like rapid clearance and targeted delivery.
- Effective delivery systems are crucial to enhance siRNA efficacy in HIV treatment.
Purpose of the Study:
- To develop a novel nanoparticle system for targeted siRNA delivery and HIV-1 neutralization.
- To overcome immune recognition and enhance therapeutic outcomes for HIV.
Main Methods:
- Functionalizing lipid nanoparticles with lymphocyte membrane and 12p1 for siRNA delivery.
- Evaluating the system's ability to escape mononuclear phagocyte uptake.
- Assessing HIV-1 neutralizing capacity through binding with gp120 and measuring inhibitory concentrations (IC80).
- Confirming specific siRNA delivery into HIV-1-infected cells and gene silencing of tat and rev.
Main Results:
- The constructed system effectively escapes mononuclear phagocyte uptake.
- Demonstrated broad and potent HIV-1 neutralization with low IC80 values for various HIV-1 strains.
- Achieved specific siRNA delivery into the cytoplasm of HIV-1-infected cells.
- Showcased significant gene silencing of HIV-1 tat and rev genes.
Conclusions:
- The developed nanoparticle system exhibits both HIV-1 neutralization and targeted siRNA delivery capabilities.
- This system represents a promising therapeutic candidate for precise HIV therapy.
- Overcoming siRNA clearance and delivery issues could revolutionize HIV treatment strategies.
